This paper updates previous assessments of how crop biotechnology has changed the environmental impact of global agriculture. It focuses on the environmental impacts associated with changes in pesticide use and greenhouse gas emissions arising from the use of GM crops since their first widespread commercial use in the mid 1990s. The adoption of GM insect resistant and herbicide tolerant technology has reduced pesticide spraying by 553 million kg (-8.6%) and, as a result, decreased the environmental impact associated with herbicide and insecticide use on these crops (as measured by the indicator the Environmental Impact Quotient (EIQ)) by 19.1%. The technology has also facilitated important cuts in fuel use and tillage changes, resulting in a significant reduction in the release of greenhouse gas emissions from the GM cropping area. In 2013, this was equivalent to removing 12.4 million cars from the roads.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033196PMC
http://dx.doi.org/10.1080/21645698.2015.1025193DOI Listing

Publication Analysis

Top Keywords

environmental impact
12
environmental impacts
8
greenhouse gas
8
gas emissions
8
environmental
5
impacts genetically
4
genetically modified
4
modified crop
4
crop 1996-2013
4
1996-2013 impacts
4

Similar Publications

Cancer and Secretomes: HLA-G and Cancer Puzzle.

Adv Exp Med Biol

January 2025

Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Among the mechanisms, cancer cells develop to elude immune system, immune regulation and the use of molecules that play important roles in immune escape stand out. One of these molecules, the human leukocyte antigen G (HLA-G), plays an important role in the maintenance of immune tolerance and contributes to the progression of cancer by exerting an immunosuppressive effect. By creating an immunosuppressive field in the microscopic environment of the tumor, the aberrant expression of HLA-G facilitates the evading of cancer cells from the immune system and contributes to the progression of the disease.

View Article and Find Full Text PDF

Boosting the catalytic efficiency of UGT51 for efficient production of rare ginsenoside Rh2.

Folia Microbiol (Praha)

January 2025

Biofuels Institute, School of Emergency Management, School of the Environment and Safety Engineering, Jiangsu University, Zhenjiang, 212013, China.

Ginsenoside Rh2(S) is well-known for its therapeutic potential against diverse conditions, including some cancers, inflammation, and diabetes. The enzymatic activity of uridine diphosphate glycosyltransferase 51 (UGT51) from Saccharomyces cerevisiae plays a pivotal role in the glycosylation process between UDP-glucose (donor) and protopanaxadiol (acceptor), to form ginsenoside Rh2. However, the catalytic efficiency of the UGT51 has remained a challenging task.

View Article and Find Full Text PDF

Three months before the planned implementation of the European Union Regulation on Deforestation-free products, the European Commission proposed to postpone the implementation by twelve months. The announcement raised the temperature in the debate on this regulation. We put forward suggestions, based on scientific knowledge as well as current EUDR research and implementation projects, on how the 12-month phasing-in period could be used wisely to promote sustainability transitions in deforestation-risk value chains.

View Article and Find Full Text PDF

Hypertension, dyslipidemia, and type 2 diabetes are highly prevalent and poorly controlled cardiometabolic diseases in the Middle East. Therapeutic non-adherence and therapeutic inertia are major contributors to this suboptimal disease control. Regardless of the cardiometabolic disease, evidence-based solutions may be used to improve therapeutic non-adherence and overcome inertia, and thereby help to alleviate the heavy burden of cardiovascular disease in the Middle East.

View Article and Find Full Text PDF

Unlocking a Decade of Research on Embryo-Derived Extracellular Vesicles: Discoveries Made and Paths Ahead.

Stem Cell Rev Rep

January 2025

Department of Internal Medicine, Reproduction and Population Health, Faculty of Veterinary Medicine, University of Ghent, Salisburylaan 133, Merelbeke, B-9820, Belgium.

Over the past decade, research on embryo-derived extracellular vesicles (EVs) has unveiled their critical roles in embryonic development and intercellular communication. EVs secreted by embryos are nanoscale lipid bilayer vesicles that carry bioactive cargo, including proteins, lipids, RNAs, and DNAs, reflecting the physiological state of the source cells. These vesicles facilitate paracrine and autocrine signaling, influencing key processes such as cell differentiation, embryo viability, and endometrial receptivity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!